Medicure (MCUJF) Total Current Liabilities (2009 - 2026)
Medicure's (MCUJF) quarterly Total Current Liabilities came in at $7.6 million in Q1 2026, up 17.4% year-on-year from $6.4 million in Q1 2025, and down 9.26% quarter-over-quarter from $8.3 million in Q4 2025.
Medicure (MCUJF) Total Current Liabilities (2009 - 2026) Analysis & Trends
Medicure's Total Current Liabilities history runs 18 years deep, the most recent figure standing at $7.6 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 17.4% year-over-year to $7.6 million in Q1 2026; TTM through Mar 2026 was $7.6 million, a 17.4% increase from a year earlier, with the FY2025 full-year figure at $8.3 million, up 35.55% from the prior year.
- Total Current Liabilities retreated to $7.6 million in Q1 2026 per MCUJF's latest filing, from $8.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $8.3 million in Q4 2025 and bottomed at $5.0 million in Q3 2023.
- The 5-year median for Total Current Liabilities is $6.2 million (2022), against an average of $6.4 million.
- Across the five-year window, Total Current Liabilities plunged 31.71% in 2022 and soared 38.57% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $6.2 million in 2022, then dropped by 5.71% to $5.8 million in 2023, then climbed by 3.12% to $6.0 million in 2024, then surged by 38.57% to $8.3 million in 2025, then retreated by 9.26% to $7.6 million in 2026.
- Per Business Quant, the three latest MCUJF Total Current Liabilities figures stand at $7.6 million (Q1 2026), $8.3 million (Q4 2025), and $6.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | 7.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.56 Mn |
| Dec 31, 2025 | 8.33 Mn |
| Sep 30, 2025 | 6.46 Mn |
| Jun 30, 2025 | 6.85 Mn |
| Mar 31, 2025 | 6.44 Mn |
| Dec 31, 2024 | 6.01 Mn |
| Sep 30, 2024 | 5.83 Mn |
| Jun 30, 2024 | 6.22 Mn |
| Mar 31, 2024 | 5.91 Mn |
| Dec 31, 2023 | 5.83 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Mar 31, 2023 | 5.62 Mn |
| Dec 31, 2022 | 6.18 Mn |
| Sep 30, 2022 | 5.88 Mn |
| Jun 30, 2022 | 7.85 Mn |
| Mar 31, 2022 | 6.41 Mn |
| Dec 31, 2021 | 6.75 Mn |
| Sep 30, 2021 | 8.62 Mn |
| Jun 30, 2021 | 9.24 Mn |
| Mar 31, 2021 | 9.04 Mn |